These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21871882)

  • 21. Activation of phosphoinositide 3-kinase/PKB pathway by CB(1) and CB(2) cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction.
    Sánchez MG; Ruiz-Llorente L; Sánchez AM; Díaz-Laviada I
    Cell Signal; 2003 Sep; 15(9):851-9. PubMed ID: 12834810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells.
    Gkoumassi E; Dekkers BG; Dröge MJ; Elzinga CR; Schmidt M; Meurs H; Zaagsma J; Nelemans SA
    Br J Pharmacol; 2007 Aug; 151(7):1041-8. PubMed ID: 17558435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630.
    Ross RA; Brockie HC; Stevenson LA; Murphy VL; Templeton F; Makriyannis A; Pertwee RG
    Br J Pharmacol; 1999 Feb; 126(3):665-72. PubMed ID: 10188977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor.
    Paugh SW; Cassidy MP; He H; Milstien S; Sim-Selley LJ; Spiegel S; Selley DE
    Mol Pharmacol; 2006 Jul; 70(1):41-50. PubMed ID: 16571654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human.
    Martin RS; Luong LA; Welsh NJ; Eglen RM; Martin GR; MacLennan SJ
    Br J Pharmacol; 2000 Apr; 129(8):1707-15. PubMed ID: 10780977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological and molecular characterization of a dorsal root ganglion cell line expressing cannabinoid CB(1) and CB(2) receptors.
    Fan Y; Hooker BA; Garrison TR; El-Kouhen OF; Idler KB; Holley-Shanks RR; Meyer MD; Yao BB
    Eur J Pharmacol; 2011 Jun; 659(2-3):161-8. PubMed ID: 21458448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sch35966 is a potent, selective agonist at the peripheral cannabinoid receptor (CB2) in rodents and primates.
    Gonsiorek W; Lunn CA; Fan X; Deno G; Kozlowski J; Hipkin RW
    Br J Pharmacol; 2007 Aug; 151(8):1262-71. PubMed ID: 17603556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological characterization of cannabinoid receptor activity in the rat-isolated ileum myenteric plexus-longitudinal muscle preparation.
    Makwana R; Molleman A; Parsons ME
    Br J Pharmacol; 2010 Apr; 159(8):1608-22. PubMed ID: 20233228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
    Desroches J; Charron S; Bouchard JF; Beaulieu P
    Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro.
    Whyte LS; Ford L; Ridge SA; Cameron GA; Rogers MJ; Ross RA
    Br J Pharmacol; 2012 Apr; 165(8):2584-97. PubMed ID: 21649637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist.
    Thomas A; Stevenson LA; Wease KN; Price MR; Baillie G; Ross RA; Pertwee RG
    Br J Pharmacol; 2005 Dec; 146(7):917-26. PubMed ID: 16205722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoids and the human uterus during pregnancy.
    Dennedy MC; Friel AM; Houlihan DD; Broderick VM; Smith T; Morrison JJ
    Am J Obstet Gynecol; 2004 Jan; 190(1):2-9; discussion 3A. PubMed ID: 14749627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CB1 cannabinoid receptor-dependent and -independent inhibition of depolarization-induced calcium influx in oligodendrocytes.
    Mato S; Alberdi E; Ledent C; Watanabe M; Matute C
    Glia; 2009 Feb; 57(3):295-306. PubMed ID: 18814177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.
    Ashton JC; Wright JL; McPartland JM; Tyndall JD
    Curr Med Chem; 2008; 15(14):1428-43. PubMed ID: 18537620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells.
    Ihenetu K; Molleman A; Parsons M; Whelan C
    Eur J Pharmacol; 2003 Mar; 464(2-3):207-15. PubMed ID: 12620515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells.
    Chiba T; Ueno S; Obara Y; Nakahata N
    J Pharm Pharmacol; 2011 May; 63(5):636-47. PubMed ID: 21492165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction.
    Felder CC; Briley EM; Axelrod J; Simpson JT; Mackie K; Devane WA
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7656-60. PubMed ID: 8395053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. O-1057, a potent water-soluble cannabinoid receptor agonist with antinociceptive properties.
    Pertwee RG; Gibson TM; Stevenson LA; Ross RA; Banner WK; Saha B; Razdan RK; Martin BR
    Br J Pharmacol; 2000 Apr; 129(8):1577-84. PubMed ID: 10780961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands.
    Liu QR; Pan CH; Hishimoto A; Li CY; Xi ZX; Llorente-Berzal A; Viveros MP; Ishiguro H; Arinami T; Onaivi ES; Uhl GR
    Genes Brain Behav; 2009 Jul; 8(5):519-30. PubMed ID: 19496827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues.
    Stamer WD; Golightly SF; Hosohata Y; Ryan EP; Porter AC; Varga E; Noecker RJ; Felder CC; Yamamura HI
    Eur J Pharmacol; 2001 Nov; 431(3):277-86. PubMed ID: 11730719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.